JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5076
Schwab 1000 Index ETF
SCHK
$5.78B
| $231K | ﹤0.01% |
10,030
-1,278
| -11% | -$27.5K |
2022 Q3
5 quarters
|
|
5077
Arcutis Biotherapeutics
ARQT
$3.16B
| $231K | ﹤0.01% |
71,465
-7,246
| -9% | -$19.7K |
2020 Q1
15 quarters
|
|
5078
Global X Autonomous & Electric Vehicles ETF
DRIV
$362M
| $231K | ﹤0.01% |
+9,347
| New | +$214K |
2023 Q4
0 quarters
|
|
5079
Northrim BanCorp
NRIM
$551M
| $230K | ﹤0.01% |
16,056
+1,112
| +7% | +$13.1K |
2023 Q1
3 quarters
|
|
5080
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$113M
| $230K | ﹤0.01% |
+9,954
| New | +$221K |
2023 Q4
0 quarters
|
|
5081
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.39B
| $230K | ﹤0.01% |
14,230
-6,000
| -30% | -$91.4K |
2022 Q4
4 quarters
|
|
5082
Vera Bradley
VRA
$147M
| $230K | ﹤0.01% |
29,806
+8,454
| +40% | +$61.5K |
2022 Q4
4 quarters
|
|
|
STRS
5083
DELISTED
STRATUS PPTYS INC
STRS
| $228K | ﹤0.01% |
7,914
+4,196
| +113% | +$114K |
2016 Q4
28 quarters
|
|
5084
Dimensional Inflation-Protected Securities ETF
DFIP
$1.1B
| $228K | ﹤0.01% |
5,531
+4,223
| +323% | +$170K |
2023 Q3
1 quarter
|
|
5085
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$360M
| $228K | ﹤0.01% |
1,976
-2,065
| -51% | -$293K |
2023 Q2
2 quarters
|
|
5086
Avita Medical
RCEL
$393M
| $228K | ﹤0.01% |
16,628
-433
| -3% | -$4.96K |
2023 Q1
3 quarters
|
|
5087
Sono-Tek
SOTK
$97.4M
| $228K | ﹤0.01% |
42,092
+42,086
| +701,433% | +$216K |
2023 Q3
1 quarter
|
|
|
SNBR
5088
DELISTED
Sleep Number
SNBR
| $227K | ﹤0.01% |
15,307
-17,251
| -53% | -$268K |
2014 Q3
37 quarters
|
|
5089
VanEck Long Muni ETF
MLN
$637M
| $227K | ﹤0.01% |
12,427
-98,254
| -89% | -$1.69M |
2023 Q3
1 quarter
|
|
5090
Norwood Financial Corp
NWFL
$367M
| $226K | ﹤0.01% |
6,877
+1,868
| +37% | +$52.6K |
2023 Q1
3 quarters
|
|
|
PAMT
5091
PAMT Corp
PAMT
$256M
| $226K | ﹤0.01% |
10,879
+5,263
| +94% | +$102K |
2016 Q4
28 quarters
|
|
5092
ProShares Short VIX Short-Term Futures ETF
SVXY
$261M
| $226K | ﹤0.01% |
4,370
-5,178
| -54% | -$238K |
2023 Q3
1 quarter
|
|
|
DRD
5093
DRDGold
DRD
$2.11B
| $226K | ﹤0.01% |
28,382
-208,837
| -88% | -$1.79M |
2023 Q2
2 quarters
|
|
|
PHLT
5094
DELISTED
Performant Healthcare Inc
PHLT
| $226K | ﹤0.01% |
72,163
+28,525
| +65% | +$74.7K |
2023 Q2
2 quarters
|
|
|
AIF
5095
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $225K | ﹤0.01% |
16,144
-2,765
| -15% | -$36.3K |
2023 Q1
3 quarters
|
|
|
EVBN
5096
DELISTED
Evans Bancorp Inc
EVBN
| $225K | ﹤0.01% |
7,139
+3,336
| +88% | +$93.4K |
2017 Q4
24 quarters
|
|
5097
1stdibs.com
DIBS
$135M
| $225K | ﹤0.01% |
48,038
+40,185
| +512% | +$170K |
2021 Q2
10 quarters
|
|
|
BAND
5098
Bandwidth Inc
BAND
$2.05B
| $224K | ﹤0.01% |
15,505
-583
| -4% | -$6.8K |
2018 Q2
22 quarters
|
|
5099
Atlanticus Holdings
ATLC
$1.39B
| $224K | ﹤0.01% |
5,791
+265
| +5% | +$8.34K |
2020 Q2
14 quarters
|
|
5100
Cardlytics
CDLX
$14.9M
| $224K | ﹤0.01% |
2,430
+137
| +6% | +$13.9K |
2018 Q1
23 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.